The impact of acetylation and deacetylation on the p53 pathway
- 1 June 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 2 (6) , 456-462
- https://doi.org/10.1007/s13238-011-1063-9
Abstract
The p53 tumor suppressor is a sequence-specific transcription factor that undergoes an abundance of post-translational modifications for its regulation and activation. Acetylation of p53 is an important reversible enzymatic process that occurs in response to DNA damage and genotoxic stress and is indispensible for p53 transcriptional activity. p53 was the first non-histone protein shown to be acetylated by histone acetyl transferases, and a number of more recent in vivo models have underscored the importance of this type of modification for p53 activity. Here, we review the current knowledge and recent findings of p53 acetylation and deacetylation and discuss the implications of these processes for the p53 pathway.Keywords
This publication has 63 references indexed in Scilit:
- The first 30 years of p53: growing ever more complexNature Reviews Cancer, 2009
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant MicePublished by Elsevier ,2008
- Combinatorial patterns of histone acetylations and methylations in the human genomeNature Genetics, 2008
- Acetylation Is Indispensable for p53 ActivationPublished by Elsevier ,2008
- Negative regulation of the deacetylase SIRT1 by DBC1Nature, 2008
- SIRT1 Regulates the Function of the Nijmegen Breakage Syndrome ProteinMolecular Cell, 2007
- ASPP: a new family of oncogenes and tumour suppressor genesBritish Journal of Cancer, 2007
- Acetylation of the p53 DNA-Binding Domain Regulates Apoptosis InductionPublished by Elsevier ,2006
- Calorie restriction, SIRT1 and metabolism: understanding longevityNature Reviews Molecular Cell Biology, 2005
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004